About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Panacea To Market Measles Vaccine In India

by Medindia Content Team on July 11, 2006 at 6:43 PM
Font : A-A+

Panacea To Market Measles Vaccine In India

Homegrown pharma major Panacea Biotec today said it is working on four vaccines, including those for treating anthrax and Japanese encephalitis.

"We are currently working on four vaccines for anthrax, dengue, Japanese encephalitis and hepatitis-A. Phase I and II trials for anthrax vaccine have been completed, which is ready for regulatory approvals," Panacea Biotec Joint Managing Director Rajesh Jain told reporters here today.

Advertisement

The company would also set up its fifth R&D centre, with a strength of 100 scientists, in Navi Mumbai, he said adding, the centre would be operational by next year.

Panacea today entered into a manufacturing and marketing agreement with Indonesian state-run drug company, PT Bio Farma, to supply their measles vaccine in India as well as other global markets.
Advertisement

As part of the agreement, the company would procure bulk vaccines from PT Bio Farma and formulate it into a finished product, which would be sold in India and other defined global markets.

"There is a shortage of measles vaccine in the Indian market with only one company manufacturing such formulations. Panacea plans to fill this demand supply gap with this new deal," Jain said.

The medicine is expected to be ready by end of 2007 and would be available in the market by 2008, he said.

Apart from India, the company would also market the vaccine to UNICEF, African countries, Latin America, Asian region and countries in the middle east, Jain added.

Source:PTI News
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Measles Vaccination for Children Rashes Symptom Evaluation Top 10 Vaccine Myths Debunked 

Most Popular on Medindia

Loram (2 mg) (Lorazepam) Turmeric Powder - Health Benefits, Uses & Side Effects Indian Medical Journals Accident and Trauma Care A-Z Drug Brands in India The Essence of Yoga Drug Side Effects Calculator Noscaphene (Noscapine) Sanatogen Drug - Food Interactions
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Panacea To Market Measles Vaccine In India Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests